MENU

ARWR Arrowhead Pharmaceuticals Forecast, Technical & Fundamental Analysis

a developer of novel drugs to treat intractable diseases

Industry Biotechnology
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
ARWR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ARWR is expected to report earnings to fall 49.04% to -69 cents per share on February 05

Arrowhead Pharmaceuticals ARWR Stock Earnings Reports
Q4'24
Est.
$-0.69
Q3'24
Missed
by $0.39
Q2'24
Missed
by $0.85
Q1'24
Missed
by $0.55
Q4'23
Missed
by $0.44
The last earnings report on November 26 showed earnings per share of -136 cents, missing the estimate of -97 cents. With 520.04K shares outstanding, the current market capitalization sits at 2.77B.
A.I. Advisor
published General Information

General Information

a developer of novel drugs to treat intractable diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
177 E. Colorado Boulevard
Phone
+1 626 304-3400
Employees
525
Web
https://www.arrowheadpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME31.261.82
+6.18%
GameStop Corp
TSLA479.8616.84
+3.64%
Tesla
AAPL253.482.44
+0.97%
Apple
BTC.X106140.600000110.890625
+0.10%
Bitcoin cryptocurrency
SPY604.29-2.50
-0.41%
SPDR® S&P 500® ETF Trust

ARWR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ARWR has been loosely correlated with PGEN. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if ARWR jumps, then PGEN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARWR
1D Price
Change %
ARWR100%
-0.45%
PGEN - ARWR
51%
Loosely correlated
+2.46%
NTLA - ARWR
50%
Loosely correlated
-1.87%
BEAM - ARWR
48%
Loosely correlated
-1.21%
CRNX - ARWR
48%
Loosely correlated
+1.35%
FATE - ARWR
45%
Loosely correlated
-6.00%
More